<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The postoperative report of the lymph node status of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in clinical practice is not a given fact </plain></SENT>
<SENT sid="1" pm="."><plain>Among other factors, it is dependent on the experience and technique of the surgeon as well as the pathologist </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore a method like sentinel lymph node biopsy (SLNB) that identifies and provides for analysis the lymph node at highest risk for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> involvement would be highly beneficial </plain></SENT>
<SENT sid="3" pm="."><plain>Unlike in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> or <z:hpo ids='HP_0002861'>melanoma</z:hpo>, SLNB is more difficult to apply in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and is still not ready for clinical routine application for these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> entities </plain></SENT>
<SENT sid="4" pm="."><plain>However, careful patient selection and expertise of the involved specialists can improve the quality and results of SLNB in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Especially in the early stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, SLNB may be helpful to identify the earliest signs of lymphatic dissemination (thereby upstaging the patient) or to encourage a limited extent of resection </plain></SENT>
</text></document>